• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症恶病质:病理生理学及其与癌痛的关联

Cancer cachexia: Pathophysiology and association with cancer-related pain.

作者信息

Law Michelle L

机构信息

Department of Human Sciences and Design, Robbins College of Health and Human Sciences, Baylor University, Waco, TX, United States.

出版信息

Front Pain Res (Lausanne). 2022 Aug 22;3:971295. doi: 10.3389/fpain.2022.971295. eCollection 2022.

DOI:10.3389/fpain.2022.971295
PMID:36072367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9441771/
Abstract

Cachexia is a syndrome of unintentional body weight loss and muscle wasting occurring in 30% of all cancer patients. Patients with cancers most commonly leading to brain metastases have a risk for cachexia development between 20 and 80%. Cachexia causes severe weakness and fatigue and negatively impacts quality and length of life. The negative energy balance in cachectic patients is most often caused by a combination of increased energy expenditure and decreased energy intake. Basal metabolic rate may be elevated due to tumor secreted factors and a systemic inflammatory response leading to inefficiency in energy production pathways and increased energy demand by the tumor and host tissues. A growing body of research explores physiological and molecular mechanisms of metabolic dysregulation in cachexia. However, decreased energy intake and physical functioning also remain important contributors to cachexia pathogenesis. Pain associated with metastatic malignancy is significantly associated with inflammation, thus making inflammation a common link between cancer pain and cachexia. Pain may also influence appetite and food intake and exacerbate fatigue and functional decline, potentially contributing to cachexia severity. Cancer pain and cachexia often occur simultaneously; however, causal relationships remain to be established. Appropriate assessment and treatment of pain in advanced cancer patients may positively impact nutrition status and physical functioning, slowing the progression of cachexia and improving quality and length of life for patients.

摘要

恶病质是一种非自愿体重减轻和肌肉消耗的综合征,在所有癌症患者中有30%会出现。最常导致脑转移的癌症患者发生恶病质的风险在20%至80%之间。恶病质会导致严重的虚弱和疲劳,并对生活质量和寿命产生负面影响。恶病质患者的负能量平衡最常由能量消耗增加和能量摄入减少共同导致。由于肿瘤分泌因子和全身炎症反应,基础代谢率可能会升高,导致能量产生途径效率低下,以及肿瘤和宿主组织对能量的需求增加。越来越多的研究探讨了恶病质中代谢失调的生理和分子机制。然而,能量摄入减少和身体功能下降仍是恶病质发病机制的重要因素。与转移性恶性肿瘤相关的疼痛与炎症显著相关,因此炎症是癌症疼痛和恶病质之间的共同联系。疼痛还可能影响食欲和食物摄入,加剧疲劳和功能衰退,可能导致恶病质加重。癌症疼痛和恶病质常同时出现;然而,因果关系仍有待确定。对晚期癌症患者进行适当的疼痛评估和治疗可能会对营养状况和身体功能产生积极影响,减缓恶病质的进展,提高患者的生活质量和寿命。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ef/9441771/8209a03abf99/fpain-03-971295-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ef/9441771/b4a84f9151e2/fpain-03-971295-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ef/9441771/8209a03abf99/fpain-03-971295-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ef/9441771/b4a84f9151e2/fpain-03-971295-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ef/9441771/8209a03abf99/fpain-03-971295-g0002.jpg

相似文献

1
Cancer cachexia: Pathophysiology and association with cancer-related pain.癌症恶病质:病理生理学及其与癌痛的关联
Front Pain Res (Lausanne). 2022 Aug 22;3:971295. doi: 10.3389/fpain.2022.971295. eCollection 2022.
2
Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.导致恶病质-厌食综合征的中枢神经系统机制。
Nutrition. 2000 Oct;16(10):1009-12. doi: 10.1016/s0899-9007(00)00413-5.
3
Nutritional support in multimodal therapy for cancer cachexia.癌症恶病质多模式治疗中的营养支持
Support Care Cancer. 2008 May;16(5):447-51. doi: 10.1007/s00520-007-0388-7. Epub 2008 Jan 15.
4
[Recent development in research and management of cancer anorexia-cachexia syndrome].[癌症恶病质综合征的研究与管理新进展]
Gan To Kagaku Ryoho. 2005 Jun;32(6):743-9.
5
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia.癌症恶病质及其病理生理学:与肌肉减少症、厌食症和乏力的关系。
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):619-635. doi: 10.1002/jcsm.12528. Epub 2020 Mar 6.
6
What we have learned about cachexia in gastrointestinal cancer.我们对胃肠道癌症恶病质的了解。
Dig Dis. 2003;21(3):198-213. doi: 10.1159/000073337.
7
Anorexia in chronic obstructive pulmonary disease--association to cachexia and hormonal derangement.慢性阻塞性肺疾病中的厌食症——与恶病质和激素紊乱的关联。
Int J Cardiol. 2007 Jun 25;119(1):83-9. doi: 10.1016/j.ijcard.2006.07.088. Epub 2006 Oct 24.
8
Molecular therapeutic strategies targeting pancreatic cancer induced cachexia.针对胰腺癌诱导恶病质的分子治疗策略。
World J Gastrointest Surg. 2018 Dec 27;10(9):95-106. doi: 10.4240/wjgs.v10.i9.95.
9
Control of food intake and muscle wasting in cachexia.控制恶病质中的食物摄入和肌肉减少。
Int J Biochem Cell Biol. 2013 Oct;45(10):2179-85. doi: 10.1016/j.biocel.2013.07.016. Epub 2013 Jul 30.
10
Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.癌症恶病质的研究进展:受影响器官、介质和药物干预的交叉点。
Biochim Biophys Acta Rev Cancer. 2020 Apr;1873(2):188359. doi: 10.1016/j.bbcan.2020.188359. Epub 2020 Mar 25.

引用本文的文献

1
Effects of Bojungikki-Tang on immune response and clinical outcomes in NSCLC patients receiving immune checkpoint inhibitors: a randomized pilot study.补中益气汤对接受免疫检查点抑制剂治疗的非小细胞肺癌患者免疫反应和临床结局的影响:一项随机试验研究
BMC Cancer. 2025 Jul 29;25(1):1229. doi: 10.1186/s12885-025-14629-4.
2
Extracorporeal blood filtration leading to tumor growth arrest and reduced analgesic requirements in Stage IV poorly differentiated pancreatic adenocarcinoma: A case report.体外血液滤过导致IV期低分化胰腺腺癌肿瘤生长停滞并降低镇痛需求:一例报告
Oncotarget. 2025 Jul 23;16:582-586. doi: 10.18632/oncotarget.28756.
3

本文引用的文献

1
Cancer cachexia: a nutritional or a systemic inflammatory syndrome?癌症恶病质:一种营养相关还是系统性炎症综合征?
Br J Cancer. 2022 Aug;127(3):379-382. doi: 10.1038/s41416-022-01826-2. Epub 2022 May 6.
2
Managing Nutrition Impact Symptoms in Cancer Cachexia: A Case Series and Mini Review.癌症恶病质营养影响症状的管理:病例系列及小型综述
Front Nutr. 2022 Mar 3;9:831934. doi: 10.3389/fnut.2022.831934. eCollection 2022.
3
Emerging signaling mediators in the anorexia-cachexia syndrome of cancer.癌症恶病质厌食症综合征中的新兴信号转导介质。
Anti-cancer effects of genistein supplementation and moderate-intensity exercise in high-fat diet-induced breast cancer via regulation of inflammation and adipose tissue metabolism in vivo and in vitro.
染料木黄酮补充剂和中等强度运动通过体内外调节炎症和脂肪组织代谢对高脂饮食诱导的乳腺癌的抗癌作用。
BMC Complement Med Ther. 2025 Jul 2;25(1):223. doi: 10.1186/s12906-025-04968-x.
4
Poor Appetite and Survival in Patients Admitted to an Acute Palliative Care Unit for Comprehensive Palliative Care.入住急性姑息治疗病房接受综合姑息治疗患者的食欲减退与生存情况
Nutrients. 2025 May 30;17(11):1882. doi: 10.3390/nu17111882.
5
Artificial Intelligence in the Management of Malnutrition in Cancer Patients: A Systematic Review.人工智能在癌症患者营养不良管理中的应用:一项系统综述。
Adv Nutr. 2025 May 5:100438. doi: 10.1016/j.advnut.2025.100438.
6
The Impact of a Western Diet and Resistance Training in a Rat Model of Mammary Cancer.西方饮食和抗阻训练对乳腺癌大鼠模型的影响
Life (Basel). 2025 Feb 6;15(2):250. doi: 10.3390/life15020250.
7
Clenbuterol and metformin ameliorate cachexia parameters, but only clenbuterol reduces tumor growth via lipid peroxidation in Walker 256 tumor-bearing rats.克伦特罗和二甲双胍可改善恶病质参数,但只有克伦特罗通过脂质过氧化作用降低Walker 256荷瘤大鼠的肿瘤生长。
Braz J Med Biol Res. 2025 Jan 31;58:e14060. doi: 10.1590/1414-431X2024e14060. eCollection 2025.
8
Characterization of a Cancer-Induced Bone Pain Model for Use as a Model of Cancer Cachexia.一种用作癌症恶病质模型的癌症诱导性骨痛模型的特征描述。
Curr Issues Mol Biol. 2024 Nov 23;46(12):13364-13382. doi: 10.3390/cimb46120797.
9
Methodology for integrated analysis of vector- and spectroscopic bioimpedance methods.矢量和光谱生物阻抗方法的综合分析方法
J Electr Bioimpedance. 2024 Dec 17;15(1):154-161. doi: 10.2478/joeb-2024-0018. eCollection 2024 Jan.
10
Extracellular vesicles in tumor-adipose tissue crosstalk: key drivers and therapeutic targets in cancer cachexia.肿瘤-脂肪组织串扰中的细胞外囊泡:癌症恶病质的关键驱动因素和治疗靶点
Extracell Vesicles Circ Nucl Acids. 2024 Jul 23;5(3):371-396. doi: 10.20517/evcna.2024.36. eCollection 2024.
Trends Cancer. 2022 May;8(5):397-403. doi: 10.1016/j.trecan.2022.01.004. Epub 2022 Feb 18.
4
Curcumin Targeting NF-B/Ubiquitin-Proteasome-System Axis Ameliorates Muscle Atrophy in Triple-Negative Breast Cancer Cachexia Mice.姜黄素靶向 NF-B/泛素-蛋白酶体系统轴缓解三阴性乳腺癌恶病质小鼠的肌肉萎缩。
Mediators Inflamm. 2022 Jan 29;2022:2567150. doi: 10.1155/2022/2567150. eCollection 2022.
5
Activation of Akt-mTORC1 signalling reverts cancer-dependent muscle wasting.激活 Akt-mTORC1 信号转导可逆转癌症相关的肌肉消耗。
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):648-661. doi: 10.1002/jcsm.12854. Epub 2021 Nov 6.
6
Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia.肠内管饲对胰腺癌恶病质患者体重稳定、去脂体重和患者报告结局的可行性和疗效。
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1959-1968. doi: 10.1002/jcsm.12799. Epub 2021 Oct 5.
7
Autophagy in metabolic disease and ageing.自噬在代谢性疾病和衰老中的作用。
Nat Rev Endocrinol. 2021 Nov;17(11):647-661. doi: 10.1038/s41574-021-00551-9. Epub 2021 Sep 10.
8
C-Reactive Protein and Its Relationship with Pain in Patients with Advanced Cancer Cachexia: Secondary Cross-Sectional Analysis of a Multicenter Prospective Cohort Study.C反应蛋白及其与晚期癌症恶病质患者疼痛的关系:一项多中心前瞻性队列研究的二次横断面分析
Palliat Med Rep. 2021 May 5;2(1):122-131. doi: 10.1089/pmr.2021.0004. eCollection 2021.
9
Quality of Life and Symptom Burden Improve in Patients Attending a Multidisciplinary Clinical Service for Cancer Cachexia: A Retrospective Observational Review.接受癌症恶病质多学科临床服务的患者生活质量和症状负担改善:回顾性观察性研究。
J Pain Symptom Manage. 2021 Sep;62(3):e164-e176. doi: 10.1016/j.jpainsymman.2021.02.034. Epub 2021 Feb 27.
10
The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.盐酸氨基酮戊酸片治疗非小细胞肺癌、胃癌、胰腺癌和结直肠癌患者恶液质的日本监管批准:事实和数据。
J Cachexia Sarcopenia Muscle. 2021 Feb;12(1):14-16. doi: 10.1002/jcsm.12675. Epub 2020 Dec 31.